These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15288477)

  • 21. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells.
    Kannan R; Zhang N; Sreekumar PG; Spee CK; Rodriguez A; Barron E; Hinton DR
    Mol Vis; 2006 Dec; 12():1649-59. PubMed ID: 17200665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
    Corradini SG; Morini S; Liguori F; Carotti S; Muda AO; Burza MA; Siciliano M; Molinaro A; Cantafora A; Blotta I; Merli M; Berloco P; Rossi M; Attili AF; Gaudio E
    Liver Int; 2009 Jan; 29(1):103-12. PubMed ID: 18544126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor protects hepatoma cells against oxidative stress-induced cell death.
    Osada S; Imai H; Tomita H; Tokuyma Y; Okumura N; Sakashita F; Nonoka K; Sugiyama Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):988-93. PubMed ID: 16724983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells.
    Ghassemifar R; Lai CM; Rakoczy PE
    Cell Tissue Res; 2006 Jan; 323(1):117-25. PubMed ID: 16163490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
    Pang R; Poon RT
    Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
    de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
    J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.
    Tsunedomi R; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Somura H; Yamada M; Oka M
    Clin Cancer Res; 2008 Feb; 14(4):1025-31. PubMed ID: 18281534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
    Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
    Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells.
    Spoerri PE; Afzal A; Li Calzi S; Shaw LC; Cai J; Pan H; Boulton M; Grant MB
    Mol Vis; 2006 Jan; 12():32-42. PubMed ID: 16446700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein-binding protein suppresses growth of hepatocellular carcinoma by anti-angiogenic activity.
    Lu L; Yang Z; Zhu B; Fang S; Yang X; Cai W; Li C; Ma JX; Gao G
    Cancer Lett; 2007 Nov; 257(1):97-106. PubMed ID: 17714861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.